Lupin gains on launching heart drug in Canada
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin, launched Propranolol LA (long-acting) capsules of 60 mg, 80 mg, 120 mg and 160 mg, in Canada
Source: moneycontrol.com
Stay updated with breaking news from Pharma Canada Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin, launched Propranolol LA (long-acting) capsules of 60 mg, 80 mg, 120 mg and 160 mg, in Canada
/PRNewswire/ -- Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin Limited (Lupin), today announced the launch of Propranolol LA (long-acting)...